Abstract: Phishing attacks remain a critical threat in the digital era, exploiting social engineering tactics to compromise user trust and sensitive information, often resulting in financial loss and ...

Overview: Free YouTube channels provide structured playlists covering AI, ML, and analytics fundamentals.Practical coding demonstrations help build real-world d ...

Warren’s appointment as CFO reflects the stage of Applied Energetics today. His leadership strengthens our foundation as we pursue long-term growth and increased visibility in the public markets.” — ...

Machine learning is an essential component of artificial intelligence. Whether it’s powering recommendation engines, fraud detection systems, self-driving cars, generative AI, or any of the countless ...

Artificial intelligence (AI) data center construction is booming—but its biggest name isn’t automatically the best investment. Meanwhile, a slower-growing tech sector is proving highly profitable for ...

Investors eyeing a purchase of Applied Digital Corporation (Symbol: APLD) stock, but cautious about paying the going market price of $35.55/share, might benefit from considering selling puts among the ...

A holistic financial plan goes beyond savings and investments to include taxes, risk management, retirement goals and legacy—here’s how to approach it Written By Written by Staff Money Writer, WSJ | ...

This is Part 6 of a series on AI in education. See Part 1 here. In Johann Wolfgang von Goethe's 1797 poem "The Sorcerer's Apprentice" (later immortalized by Walt Disney), a trainee makes a broom fetch ...

CHONGQING, CHINA - SEPTEMBER 28: In this photo illustration, a hand holds a smartphone displaying the logo of Applied Digital Corporation (NASDAQ: APLD), the American company specializing in data ...

Valve’s second big foray into first-party PC hardware isn’t a sequel to the much-imitated Steam Deck portable, but rather a desktop computer called the Steam Machine. And while it could go on your ...

– Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes – Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the ...